Exercise Rehabilitation of Younger and Older People With Claudication
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine the effect of age and the effect of exercise intensity of rehabilitation programs on claudication pain symptoms and leg circulation of younger and older patients with intermittent claudication.
| Condition | Intervention |
|---|---|
|
Intermittent Claudication |
Behavioral: Walking Exercise |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Exercise Rehabilitation of Younger and Older People With Claudication |
- Change in the walking distance to onset of leg pain, and the change in walking distance to maximal leg pain. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Changes in cardiopulmonary function, calf muscle circulation, and health-related quality of life. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 64 |
| Study Start Date: | February 1994 |
| Study Completion Date: | January 2000 |
| Primary Completion Date: | January 2000 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Low intensity group (40% of maximal exercise capacity)
|
Behavioral: Walking Exercise
Intermittent treadmill walking to near maximal claudication pain three days per week
|
|
Experimental: 2
High intensity group (80% of maximal exercise capacity)
|
Behavioral: Walking Exercise
Intermittent treadmill walking to near maximal claudication pain three days per week
|
Detailed Description:
Thirty-one patients randomized to low-intensity exercise rehabilitation and 33 patients randomized to high-intensity exercise rehabilitation completed the study. The 6-month exercise rehabilitation programs consisted of intermittent treadmill walking to near maximal claudication pain three days per week at either 40% (low-intensity group) or 80% (high-intensity group) of maximal exercise capacity. Total work performed in the two training regimens was similar by having the patients in the low-intensity group exercise for a longer duration than patients in the high-intensity group. Measurements of physical function, peripheral circulation, and health-related quality of life were obtained on each patient before and after the rehabilitation programs.
Eligibility| Ages Eligible for Study: | 45 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- History of intermittent claudication
- Exercise tolerance limited by intermittent claudication during a screening treadmill test
- Ankle/brachial index (ABI) at rest less than 0.90
- Live independently at home
Exclusion Criteria:
- Absence of PAD (peripheral artery disease)
- Asymptomatic PAD (Fontaine stage I)
- Rest pain PAD (Fontaine stage III)
- Exercise tolerance limited by factors other than claudication (e.g., coronary artery disease, dyspnea, poorly controlled blood pressure)
- Active cancer, renal disease, or liver disease
- Current use of pentoxifylline or cilostazol medications for the treatment of intermittent claudication
Contacts and Locations
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Andrew W. Gardner, PhD, University of Oklahoma Health Sciences Center |
| ClinicalTrials.gov Identifier: | NCT00654810 History of Changes |
| Other Study ID Numbers: | AG0097, K01-AG-00657 |
| Study First Received: | April 7, 2008 |
| Last Updated: | April 7, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute on Aging (NIA):
|
functional ability gait musculoskeletal disorder therapy peripheral blood vessel disorder |
Additional relevant MeSH terms:
|
Intermittent Claudication Arteriosclerosis Arterial Occlusive Diseases |
Vascular Diseases Cardiovascular Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013